{"id":"https://openalex.org/W200086805","doi":null,"title":"Very low-dose lenalidomide therapy for elderly multiple myeloma patients.","display_name":"Very low-dose lenalidomide therapy for elderly multiple myeloma patients.","publication_year":2013,"publication_date":"2013-05-01","ids":{"openalex":"https://openalex.org/W200086805","mag":"200086805","pmid":"https://pubmed.ncbi.nlm.nih.gov/23727684"},"language":"ja","primary_location":{"id":"pmid:23727684","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/23727684","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"[Rinsho ketsueki] The Japanese journal of clinical hematology","raw_type":"Journal Article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5052453190","display_name":"Kentaro Minagawa","orcid":"https://orcid.org/0000-0003-1740-7109","observed_orcids":["https://orcid.org/0000-0003-1740-7109"]},"institutions":[{"id":"https://openalex.org/I65837984","display_name":"Kobe University","ror":"https://ror.org/03tgsfw79","country_code":"JP","type":"education","lineage":["https://openalex.org/I65837984"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Kentaro Minagawa","raw_affiliation_strings":["Hematology, Department of Medicine, Kobe University Graduate School of Medicine"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hematology, Department of Medicine, Kobe University Graduate School of Medicine","institution_ids":["https://openalex.org/I65837984"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102516677","display_name":"Hiroki Kawano","orcid":"https://orcid.org/0009-0005-6560-6657","observed_orcids":["https://orcid.org/0009-0005-6560-6657"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Hiroki Kawano","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109867125","display_name":"Takuma Suzuki","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Takuma Suzuki","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5011305437","display_name":"Tadahiro Inagaki","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Tadahiro Inagaki","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5003136392","display_name":"Minoru Kishi","orcid":"https://orcid.org/0009-0001-5585-4519","observed_orcids":["https://orcid.org/0009-0001-5585-4519"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Minoru Kishi","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5064642713","display_name":"Tamaki Hirata","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Tamaki Hirata","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":null,"display_name":"Sachiko Kimura","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Sachiko Kimura","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5083729467","display_name":"Miho Takechi","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Miho Takechi","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111601251","display_name":"Toru Koide","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Toru Koide","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":null,"display_name":"Masahide Iwai","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Masahide Iwai","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5045899521","display_name":"Yoshio Katayama","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Yoshio Katayama","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5101711253","display_name":"Toshimitsu Matsui","orcid":"https://orcid.org/0000-0002-2536-7584","observed_orcids":["https://orcid.org/0000-0002-2536-7584"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Toshimitsu Matsui","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":3,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":96},"biblio":{"volume":"54","issue":"5","first_page":"457","last_page":"62"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10649","display_name":"Multiple Myeloma Research and Treatments","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10649","display_name":"Multiple Myeloma Research and Treatments","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12534","display_name":"Protein Degradation and Inhibitors","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11221","display_name":"Bone health and treatments","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/lenalidomide","display_name":"lenalidomide","score":0.996999979019165},{"id":"https://openalex.org/keywords/multiple-myeloma","display_name":"multiple myeloma","score":0.9120000004768372},{"id":"https://openalex.org/keywords/elderly-patients","display_name":"elderly patients","score":0.9980000257492065},{"id":"https://openalex.org/keywords/refractory-multiple-myeloma","display_name":"refractory multiple myeloma","score":0.8489999771118164},{"id":"https://openalex.org/keywords/relapsed-multiple-myeloma","display_name":"relapsed multiple myeloma","score":0.9769999980926514},{"id":"https://openalex.org/keywords/dose-reduction","display_name":"dose reduction","score":0.859000027179718},{"id":"https://openalex.org/keywords/adverse-effects","display_name":"adverse effects","score":0.6790000200271606},{"id":"https://openalex.org/keywords/infection","display_name":"infection","score":0.8669999837875366},{"id":"https://openalex.org/keywords/hematological-toxicity","display_name":"hematologic toxicity","score":0.9200000166893005},{"id":"https://openalex.org/keywords/outpatient-care","display_name":"outpatient care","score":0.5429999828338623}],"concepts":[{"id":"https://openalex.org/C2776063141","wikidata":"https://www.wikidata.org/wiki/Q425681","display_name":"Lenalidomide","level":3,"score":0.969342052936554},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9605611562728882},{"id":"https://openalex.org/C2776364478","wikidata":"https://www.wikidata.org/wiki/Q467635","display_name":"Multiple myeloma","level":2,"score":0.795721173286438},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.7589551210403442},{"id":"https://openalex.org/C142424586","wikidata":"https://www.wikidata.org/wiki/Q7307572","display_name":"Refractory (planetary science)","level":2,"score":0.5058686137199402},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5026869773864746},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.38036778569221497},{"id":"https://openalex.org/C121332964","wikidata":"https://www.wikidata.org/wiki/Q413","display_name":"Physics","level":0,"score":0.0},{"id":"https://openalex.org/C87355193","wikidata":"https://www.wikidata.org/wiki/Q411","display_name":"Astrobiology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000077269","descriptor_name":"Lenalidomide","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000284","descriptor_name":"Administration, Oral","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000369","descriptor_name":"Aged, 80 and over","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003907","descriptor_name":"Dexamethasone","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D004334","descriptor_name":"Drug Administration Schedule","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004359","descriptor_name":"Drug Therapy, Combination","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005938","descriptor_name":"Glucocorticoids","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007155","descriptor_name":"Immunologic Factors","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D007155","descriptor_name":"Immunologic Factors","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D009101","descriptor_name":"Multiple Myeloma","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D012189","descriptor_name":"Retrospective Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013792","descriptor_name":"Thalidomide","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D013792","descriptor_name":"Thalidomide","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D013792","descriptor_name":"Thalidomide","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"pmid:23727684","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/23727684","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"[Rinsho ketsueki] The Japanese journal of clinical hematology","raw_type":"Journal Article"},{"id":"mag:200086805","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/23727684","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Case Report","id":"https://openalex.org/study-designs/case-report"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W3082423675","https://openalex.org/W2526724919","https://openalex.org/W2916409947","https://openalex.org/W2160695989","https://openalex.org/W3023054673","https://openalex.org/W2736927293","https://openalex.org/W2738964185","https://openalex.org/W2588657525","https://openalex.org/W3088485675","https://openalex.org/W3136849454"],"abstract_inverted_index":{"Lenalidomide":[0],"treatment":[1,48],"for":[2,112,122],"refractory":[3],"or":[4],"relapsed":[5],"multiple":[6],"myeloma":[7,50],"in":[8,14,33,38,51,119],"elderly":[9,53,123],"patients":[10,54,67,124],"may":[11],"be":[12,132],"feasible":[13],"an":[15,75],"outpatient":[16],"setting.":[17],"However,":[18],"difficulties":[19],"have":[20],"been":[21,36],"associated":[22],"with":[23,59,74,84],"the":[24,46,97,106,147],"management":[25],"of":[26,49,108,149],"adverse":[27,89,114],"effects.":[28],"Therefore,":[29],"a":[30,71,116,127,141],"dose":[31,117,130],"reduction":[32,118],"lenalidomide":[34,62,120,151],"has":[35],"recommended":[37],"some":[39],"cases.":[40],"In":[41],"this":[42],"report,":[43],"we":[44],"encountered":[45],"successful":[47],"6":[52],"(aged":[55],"above":[56],"70":[57],"years)":[58],"very":[60,128],"low-dose":[61,150],"(5":[63],"mg":[64],"daily).":[65],"Four":[66],"exhibited":[68],"more":[69],"than":[70],"partial":[72],"response":[73],"8.6":[76],"months":[77],"median":[78],"follow-up":[79],"period,":[80],"which":[81,94],"was":[82,92],"comparable":[83],"previous":[85],"findings.":[86],"The":[87],"major":[88],"effect":[90],"observed":[91],"infection,":[93],"occurred":[95],"during":[96],"first":[98],"several":[99],"cycles.":[100],"Others":[101],"were":[102],"less":[103],"toxic,":[104],"especially":[105],"absence":[107],"grade":[109],"3/4":[110],"toxicities":[111],"hematological":[113],"effects.Although":[115],"therapy":[121],"is":[125,138],"controversial,":[126],"low":[129],"could":[131],"safe":[133],"and":[134],"effective.":[135],"Our":[136],"group":[137],"currently":[139],"conducting":[140],"multi-center":[142],"prospective":[143],"trial":[144],"to":[145],"evaluate":[146],"efficacy":[148],"therapy.":[152]},"counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2017,"cited_by_count":2}],"updated_date":"2026-11-02T09:45:03.842371","created_date":"2016-06-24T00:00:00"}